Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase 1, Open-Label, Multi-Center, Safety and Efficacy Study of PRT12396 in Participants With Polycythemia Vera and Myelofibrosis

This is a first-in-human, open-label, multi-center Phase 1 study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of P…

Polycythemia Vera (PV)Myelofibrosis (MF)Myeloproliferative Neoplasms (MPNs)+3 more

Estimated

~$10 – $8,750

Prelude Therapeutics IncorporatedNCT07469891

Pacritinib Effectiveness in Real-world Settings (PACER)

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a …

Myelofibrosis (MF)

Estimated

~$10 – $1,125

Swedish Orphan BiovitrumNCT07774455

Phase 1

TACTICAL: TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

The purpose of this study is to test the feasibility and safety of early cessation of tacrolimus following allogeneic hematopoietic cell transplantation (HCT).…

GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more

Estimated

~$10 – $6,250

Stanford UniversityNCT07302776

Phase 1

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

* To find the recommended dose of axatilimab given alone and in combination with ruxolitinib in patients with MF and CMML. * To learn if axatilimab given in co…

Myelofibrosis (MF)Chronic Myelomonocytic Leukemia (CMML)

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07128381

The MPN PROGRESSion Registry: A Retrospective and Prospective Observational Study Collecting Patient-Reported Outcomes, Electronic Health Records, and Claims Data to Track Symptoms, Treatments, and Disease Progression in Individuals Diagnosed With Myeloproliferative Neoplasms (MPNs).

The MPN PROGRESSion Registry is a multi-year, observational research study designed to improve understanding of myeloproliferative neoplasms (MPNs)-a group of …

Polycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more

Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT06541249